Large-scale testing (Phase 3)UnknownNCT02961426What this trial is testingStrategic Transformation of the Market of HCV TreatmentsWho this might be right forHepatitis C Drugs for Neglected Diseases 603
Early research (Phase 1)Ended earlyNCT01567540What this trial is testingA Pilot Study Evaluating Safety of Sitagliptin Combined With Peg-IFN Alfa-2a + Ribavirin in Chronic Hepatitis C PatientsWho this might be right forHepatitis C Institut National de la Santé Et de la Recherche Médicale, France 3
Early research (Phase 1)Study completedNCT02210182What this trial is testingA Phase I Clinical Study on a New Oral Pentamidine Formulation in Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Oncozyme Pharma Inc. 29
Testing effectiveness (Phase 2)Study completedNCT00105235What this trial is testingImmune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation PatientsWho this might be right forLiver DiseaseLiver Transplantation National Institute of Allergy and Infectious Diseases (NIAID) 27
Early research (Phase 1)UnknownNCT02650375What this trial is testingStudy of Metatinib Tromethamine TabletWho this might be right forAdvanced or Metastatic Gastric CancerAdvanced or Metastatic Liver CancerAdvanced or Metastatic CRC+1 more Jiangsu Simcere Pharmaceutical Co., Ltd. 24
Post-approval studies (Phase 4)Study completedNCT00522730What this trial is testingSafety and Tolerance on Lipids of Parenteral and Enteral Nutrition in Critically Ill Patients With Liver FailureWho this might be right forLiver FailureCritical Illness Cliniques universitaires Saint-Luc- Université Catholique de Louvain 45
Not applicableStudy completedNCT00536250What this trial is testingStudy to Investigate the Pathophysiology of Type 2 Diabetes in YouthWho this might be right forImpaired Glucose TolerancePre-diabetesChildhood Obesity+2 more Yale University 255
Testing effectiveness (Phase 2)Study completedNCT00000654What this trial is testingThe Tolerance of HIV-Infected Patients With Herpes Group Virus Infections to Oral Doses of FIAUWho this might be right forHerpes SimplexHIV InfectionsHepatitis B National Institute of Allergy and Infectious Diseases (NIAID) 78
Not applicableEnrolling By InvitationNCT07445347What this trial is testingEfficacy and Tolerance of Treatment With Bevacizumab for Severe Liver Involvement With High Cardiac Output in Hereditary Hemorrhagic Telangiectasia Within the French Hereditary Hemorrhagic Telangiectasia NetworkWho this might be right forHereditary Hemorrhagic Telangiectasia (HHT)Pulmonary HypertensionBevacizumab Poitiers University Hospital 111
Testing effectiveness (Phase 2)Active Not RecruitingNCT06151964What this trial is testingA Trial to Learn How Safe AZD9550 Monotherapy and Combined With AZD6234 is in People With or Without Type 2 Diabetes Who Are Living With Obesity and OverweightWho this might be right forOverweight and Obesity AstraZeneca 118
Testing effectiveness (Phase 2)UnknownNCT00647283What this trial is testingAssessment Of the Safety and Benefit of Prospective Immunosuppressive Drug Withdrawal in Liver Transplantation and Prediction of Operational ToleranceWho this might be right forLiver Transplantation Hospital Clinic of Barcelona 80
Not applicableWithdrawnNCT05229640What this trial is testingRelationship Between the Development of Impaired Glucose Tolerance, the Phenotype of CFLD, and the Risk of Liver FibrosisWho this might be right forCF - Cystic FibrosisCystic Fibrosis-related DiabetesCystic Fibrosis Liver Disease Dartmouth-Hitchcock Medical Center
Not applicableStudy completedNCT01237002What this trial is testingPringle Time Exceeding 120 Min in Liver ResectionWho this might be right forTolerance of the Liver University of Milan 189
Early research (Phase 1)Study completedNCT05391360What this trial is testingEvaluation Freethiadine Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of StudyWho this might be right forHepatitis B, Chronic Sunshine Lake Pharma Co., Ltd. 128
Not applicableLooking for participantsNCT06704321What this trial is testingEffects of TOTUM-448 on Liver Fat Content, Cardiometabolic Risk Factors and Gut Microbiota Among Participants with MASLDWho this might be right forNon-Alcoholic Fatty Liver Disease Valbiotis 70
Not applicableUnknownNCT01065584What this trial is testingAn Observational Study to Assess the Effect of Calcineurin Inhibitors on Markers of Transplant ToleranceWho this might be right forLiver Transplantation University Medical Center Goettingen 58
Testing effectiveness (Phase 2)Study completedNCT02533180What this trial is testingEvaluation of Donor Specific Immune Senescence and Exhaustion as Biomarkers of Tolerance Post Liver TransplantationWho this might be right forLiver TransplantLiver Transplantation National Institute of Allergy and Infectious Diseases (NIAID) 100
Testing effectiveness (Phase 2)Ended earlyNCT02314052What this trial is testingPhase Ib/2, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Dicerna Pharmaceuticals, Inc., a Novo Nordisk company 21
Not applicableStudy completedNCT02381769What this trial is testingTHE IMMUNOLOGICAL EFFECTS AND METABOLIC TOLERANCE OF LIPID INFUSION IN PATIENTS WITH CIRRHOSIS.Who this might be right forAlcoholic Liver Disease Institute of Liver and Biliary Sciences, India 55
Testing effectiveness (Phase 2)UnknownNCT00438737What this trial is testingCetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal CancerWho this might be right forColorectal CancerMetastatic Cancer European Organisation for Research and Treatment of Cancer - EORTC 100